Français
ItalianoBond Gilead Sciences 0% ( US375558BN20 ) in USD
| Issuer | Gilead Sciences | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US375558BN20 ( in USD )
|
||||||
| Interest rate | 0% | ||||||
| Maturity | 20/09/2018 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 1 000 000 000 USD | ||||||
| Cusip | 375558BN2 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BN20, pays a coupon of 0% per year. The coupons are paid 2 times per year and the Bond maturity is 20/09/2018 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BN20, was rated NR by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558BN20, was rated NR by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||
